Top Pharmaceutical Litigation Trends To Watch

As the health care & life sciences industry continues to evolve, organizations across the country should be mindful of recent trends in pharmaceutical litigation. Whether it is antirust, intellectual property, mass tort litigation, or other litigation issues, this webinar dives into the pharmaceutical trends that are on the rise in the industry.

Foley’s Health Care & Life Sciences Sector and Pharmaceuticals & Other Regulated Drugs Area of Focus invite you to join us for a webinar to discuss the top pharmaceutical litigation trends that are affecting the health care and life sciences industry.

This webinar will focus on:

1. Consent decrees in the pharmaceutical industry and FDA’s views on drug litigation,
2. How intellectual property litigation will affect pharmaceutical companies,
3. Government enforcement policy changes and supply chain concerns,
4. Telemedicine companies facing litigation concerns over GLP-1 drugs,
5. Competition amongst pharmaceutical companies with counterfeit drug labeling and;
6. Regulation and enforcement of pharmaceutical pricing practices.

To watch the recording, click here.

CLE

Applications for accreditation will be submitted to CA, CO, FL, IL, NY, TX, UT, VA, and WI. Uniform Certificates of Attendance will be provided to attendees licensed in other jurisdictions so they may self-apply if their jurisdiction allows.

Foley & Lardner LLP is an approved MCLE provider in California, Colorado, Illinois, New York, Texas, and Utah.
For purposes of New York CLE credit, this program is appropriate for both newly admitted and experienced attorneys.

Certificates of attendance will be distributed to eligible participants approximately eight weeks after the program via email.